Report of Foreign Issuer (6-k)
April 15 2019 - 8:34AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16
OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of April 2019
Commission file number:
001-38556
ENTERA BIO LTD.
(Exact Name of Registrant as Specified in Its Charter)
Kiryat Hadassah
Minrav Building – Fifth Floor
Jerusalem, Israel
(Address of principal executive office)
_____________________
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☒
Form 40-F ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
CONTENTS
Enclosed hereto and incorporated herein by reference are copies of the following items being furnished by Entera Bio Ltd. (
“
Entera
”
) in connection with its annual general meeting of shareholders (the
“
Meeting
”
) to be held at Entera
’
s offices, located at Kiryat Hadassah, Minrav Building - Fifth Floor, Jerusalem, Israel, on Monday, May 20, 2019 at 5:00 p.m., Israel time:
Exhibits
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
|
ENTERA BIO LTD.
(Registrant)
|
|
|
|
|
|
|
|
|
By:
|
/s/ Dr. Philip Schwartz
|
|
|
|
|
Name: Philip Schwartz
|
|
|
|
|
Title: Chief Executive Officer
|
|
|
|
|
|
|
Date: April 15, 2019
3
Entera Bio (NASDAQ:ENTX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Entera Bio (NASDAQ:ENTX)
Historical Stock Chart
From Apr 2023 to Apr 2024
